Business
Announcement on Subsidiary’s Drug Entering Phase III Clinical Trials
Announcement on Subsidiary’s Drug Entering Phase III Clinical Trials
About this update from Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class A
Announcement on Subsidiary’s Drug Entering Phase III Clinical TrialsThe abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment